TP53 and thymus lymphoma: As expected, by performing immunoblotting, we observed significantly higher PTEN protein levels in thymic lymphomas derived from Tp53−/−; Prl2−/− mice compared with tumors derived from Tp53−/− mice (119% increase, P = 0.0014; Fig. 5A and B).